Amgen Inc.'s ( NASDAQ:AMGN ) dividend will be increasing from last year's payment of the same period to $2.38 on 7th ...
Amgen Inc. sees the potential for 2025 revenues to top Wall Street estimates thanks to growth in cholesterol and cancer drugs ...
Amgen's Q4 earnings beat expectations, showcasing robust performance for the company's growth strategy. Click here to read ...
Amgen Inc (NASDAQ:AMGN)., a leading biopharmaceutical company with a market capitalization of $155 billion, is at a pivotal juncture as it navigates the competitive landscape of innovative ...
Amgen Inc. closed 18.42% short of its 52-week high of $346.85, which the company achieved on July 25th.
Amgen leases 500,000 sq ft in Hyderabad to establish its first global capability centre, enhancing its office space in the ...
We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Amgen Inc. closed 19.88% short of its 52-week high of $346.85, which the company reached on July 25th.